MM Label Debated As FDA Word Nears On Velcade
This article was originally published in The Pink Sheet Daily
Executive Summary
Approval that includes transplant-eligible patients might not matter much, analyst says.
You may also be interested in...
Velcade Wins FDA Clearance In First-Line MM
Agency hits PDUFA date with “quite broad” new label, exec tells “The Pink Sheet” DAILY.
Velcade Wins FDA Clearance In First-Line MM
Agency hits PDUFA date with “quite broad” new label, exec tells “The Pink Sheet” DAILY.
Takeda Reaffirms Oncology Goals With $8.8 Billion Millennium Acquisition
Japanese drug maker takes a stronger position in oncology, expands U.S. presence.